Interest of multifunctional lipid excipients: case of Gelucire 44/14. - Wikidata - awgldk - TriplyDB

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

http://www.wikidata.org/entity/Q36234508

about

Lipid-Based Drug Delivery Systems.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.Gelucire and Gelucire-PEG400 formulations; tolerability in species used for non-clinical safety testing after oral (gavage) dosing.The effects of supercritical carbon dioxide processing on progesterone dispersion systems: a multivariate study.The use of quasi-isothermal modulated temperature differential scanning calorimetry for the characterization of slow crystallization processes in lipid-based solid self-emulsifying systems.Nootropic activity of lipid-based extract of Bacopa monniera Linn. compared with traditional preparation and extracts.Novel pepper extract for enhanced P-glycoprotein inhibition.Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein

P2860

Q36112195-3704B0D5-3051-411E-A744-A81398F9B368 Q37988960-9F0C5576-77D2-43BA-B64E-16818FE34B66 Q38967883-D5523FB1-047B-40B8-BE08-3071B30A8285 Q40020317-FEC66DBC-70C9-4E0E-ACF2-553947FF64A8 Q41779953-38B22CDF-F096-4E42-A6E7-0FC232C80C0C Q43183731-C401BB4A-6E41-46A2-A042-BF71E9D21497 Q43244891-6AEBE33C-8463-4951-8A11-A3EEE4A0863F Q43287004-CF218893-5C01-4228-AB6E-AB186910071A Q45353676-A2002337-BA04-4CF4-810F-54590E8B4611 Q45978265-CC14141E-6731-4EE6-A05E-DAC758DE51B1 Q46040749-1427392C-237D-40D4-B69A-FBF73C34E61A Q49157669-97064199-8660-42B8-9145-29A7F6DEEA41 Q58698851-A5CC0BEC-977D-4EFB-98CB-1D61A95F1EAF

P2860

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

http://www.wikidata.org/entity/Q36234508

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@ast

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@en

type

label

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@ast

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@en

prefLabel

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@ast

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@en

P1433

Q36234508-7668F186-5804-46FB-96E7-F41D9EE76CDA

P1476

Q36234508-2AA459B1-CE33-4533-9D02-C4D8C88B2488

P2093

Q36234508-07DE17B7-328A-4F79-A129-4290B41FDEDF

Q36234508-73F5488F-85EA-4F61-9BF7-AB2E5F249B0F

P2860

Q36234508-13C445D5-3DE4-44E7-BC24-45CE3F1FA3CE

Q36234508-1B238A5E-C7FD-4725-9F9C-7FD6230D344D

Q36234508-2F6E9DA5-1E4C-4454-861B-C0426FE3AF04

Q36234508-385BDFAB-099A-46A8-BB5E-C4484714CE85

Q36234508-4FAC5CFA-9505-4954-8BD6-A4E76A34F9D5

Q36234508-594962AE-BBC0-40C1-888D-B64D19E4A11F

Q36234508-869DCAE8-0AA6-43F3-987B-6F235D09177E

Q36234508-9A087262-C91C-4B8A-B445-31BD40269EC6

Q36234508-B1C1F174-3707-4B97-98C4-67BF64F4E98F

Q36234508-C863A890-A55A-430D-AD9D-3114D0D172E1

P304

Q36234508-C0876417-831C-4644-BBCB-CED00C37EFB9

P31

Q36234508-2D1DCC14-82DD-4957-B3EC-16E5B79D68F3

P356

Q36234508-ABCBC701-8601-4D34-ABF7-37D4F208EB53

P407

Q36234508-22AEC002-1BD3-4201-B8E9-6AA5F222E7F4

P433

Q36234508-89EAA855-3DCA-4BD2-8418-236F1B39F9B0

P478

Q36234508-EF904F93-E4CB-48E2-8562-42057259774F

P577

Q36234508-B386ED25-97B8-4CE7-B07D-E3C4A458ECF2

P698

Q36234508-4C5AC361-6786-4BCA-82B2-78F1E4AAE62C

P356

03639040500215750

P1433

Drug Development and Industrial Pharmacy

P1476

Interest of multifunctional lipid excipients: case of Gelucire 44/14.

@en

P2093

Chambin O

http://www.w3.org/2001/XMLSchema#string

Jannin V

http://www.w3.org/2001/XMLSchema#string

P2860

Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation.

The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture.

An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14.

Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

The mechanisms of drug release from solid dispersions in water-soluble polymers.

Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.

Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.

Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.

Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.

P304

527-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03639040500215750

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16109625

http://www.w3.org/2001/XMLSchema#string